Type IV collagen turnover is predictive of mortality in COPD: a comparison to fibrinogen in a prospective analysis of the ECLIPSE cohort

BACKGROUND: Identifying subjects with chronic obstructive pulmonary disease (COPD) at high risk of exacerbation and mortality is key to aid individual management of COPD. The only FDA approved blood-based drug development biomarker for patients at high risk of mortality, is plasma fibrinogen. In thi...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Respir Res
Autors principals: Rønnow, Sarah Rank, Sand, Jannie Marie Bülow, Langholm, Lasse Løcke, Manon-Jensen, Tina, Karsdal, Morten Asser, Tal-Singer, Ruth, Miller, Bruce E., Vestbo, Jørgen, Leeming, Diana Julie
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2019
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6444812/
https://ncbi.nlm.nih.gov/pubmed/30935391
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12931-019-1026-x
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars